openPR Logo
Press release

VERMES Microdispensing introduces its latest MDS 3050 series with unique features for low to medium viscous media dispensing

10-06-2021 03:12 PM CET | Industry, Real Estate & Construction

Press release from: VERMES Microdispensing

VERMES Microdispensing MDS 3050 System  for low to medium viscosity dispensing

VERMES Microdispensing MDS 3050 System for low to medium viscosity dispensing

Holzkirchen, Germany, October 5th, 2021 — VERMES Microdispensing, a world leader in the design and manufacture of innovative microdispensing concepts and systems introduces its MDS 3050 system, the newest member of the MDS 3000 series for low to medium viscosity dispensing.
The modern high precision, piezo-based jetters of the MDS 3050 series dispense minimal amounts in nano and sub-nano ranges and are suitable for a wide range of demanding industries including microelectronics, biosciences, medical diagnostics, and pharmaceutics. Namely, medical cells and protein solution dispensing are among the top applications for this new system.
The valve is normally closed, which offers perfect conditions for dispensing fluids of lower viscosity.
The new technology provides a strong actuator and an exceptional locking force and therefore allows an application specific adjustability for the different media.
The system is capable of ultimately adjusting its force and closure function to the need of the medium and thus excellently fulfills tasks such as cell survival dispensing.
“Recent advancements in the field of tissue engineering have enabled the creation of 3D living organ analogues. Since the bio-printing technology is expected to be used more and more in regenerative medicine and drug research, there is a great demand for the MDS 3050 dispenser with its specific power density and volume-force ratio,” explains Juergen Staedtler, CEO and Managing Director of VERMES Microdispensing.
VERMES Microdispensing’s latest frame technology gives the system highest reliability and provides its valve frame with exceptional stability and resistance to frame expansion and break elongation, resulting in an excellent thermal compensation.
The valve’s slim design and multi staking possibility is an attractive solution for a varied scope of applications.
The MDV 3050 is equipped with a side adjust for fast configuration and with an interchangeable tappet. The user can select from the entire range of VERMES Microdispensing’s tappets and nozzle inserts to obtain the best fit for his application.
The solution is compatible with existing VERMES Microdispensing add-ons and heaters and is available with (MDS 3050-AC) and without air-cooling (MDS 3050).
A chip inside the valve provides additional monitoring functions to achieve a continually consistent dispensing result.
The VERMES Microdispensing MDS 3050 supports high-volume, automated fast and highly accurate production processes where minimal quantities of liquid must be process-safe and perfectly dispensed.
Industries that use UV adhesives, Cyanoacrylate, anaerobic adhesives, etc. will benefit from this solution.
With this system, VERMES Microdispensing is able to dispense all media contactless and with the highest precision up to a viscosity of 8,000 mPas.

Contact
Birgitt Harrow
VERMES Microdispensing GmbH
Rudolf-Diesel-Ring 2
83607 Holzkirchen
Germany
Phone:+49 (0) 80 24-6-44-335
Fax: +49 (0) 80 24-6-44-19
pr@vermes.com
www.vermes.com

Headquartered in Germany, VERMES Microdispensing revolutionized microdispensing technology with the introduction of its contact free piezo-based MDS 3000 series in 2001. Today, the company is a world leader in the design and manufacture of innovative microdispensing concepts and systems for adhesives, silicones, greases, solvents and other fluids.

VERMES high precision MDS 3000 valves support modern manufacturing processes across the globe, e.g. for MEMS components, semiconductor, displays (LCD, OLED, micro-LED), LED, smart mobile devices, automotive, SMT, RFID tags, pharmacology, and many other electronic devices.

Our systems enable our customers to achieve contact free dispensing of highly viscous media droplets in the micro and nano and sub-nano liter range at theoretical frequencies of more than 3000 Hz - a rate that is unique in our industry.

VERMES Microdispensing employees are dedicated to providing the best technologies and services to its customers around the world with the ultimate aim of contributing to increased throughput, improved quality and lower production costs. More information about VERMES Microdispensing can be found at www.vermes.com.

VERMES Microdispensing is a trademark of VERMES Microdispensing GmbH in Germany and other countries.

Other names and brands may be claimed as the property of others.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release VERMES Microdispensing introduces its latest MDS 3050 series with unique features for low to medium viscous media dispensing here

News-ID: 2418227 • Views:

More Releases from VERMES Microdispensing

VERMES Microdispensing registers subsidiary in India in response to the move of major customers to this important market
VERMES Microdispensing registers subsidiary in India in response to the move of …
VERMES Microdispensing registers subsidiary in India in response to the move of major customers to this important market Munich, Germany - May 10th, 2023 - VERMES Microdispensing today announced the opening of its own subsidiary in India, VERMES Microdispensing India Private Limited, based in the country's IT capital, Bengaluru. VERMES Microdispensing CEO Juergen Staedtler has long held an interest in India, and now the company is setting up a spacious sales and
VERMES Microdispensing forms subsidiary in Vietnam, a country with rapidly growing importance in the value chain of the electronics industry
VERMES Microdispensing forms subsidiary in Vietnam, a country with rapidly growi …
Munich, Germany - February 28th, 2023 - VERMES Microdispensing today announced that it has formed a new subsidiary, VERMES Microdispensing Vietnam Co., Ltd, located in Bac Ninh, marking the company's entry into the industrial hub of Northern Vietnam. The area is home to several industrial parks with numerous manufacturers from the electronics, semiconductor, telecommunications, automotive and other industries. The aim is to be closer to VERMES Microdispensing's customers in Vietnam and to
VERMES Microdispensing opens new office in Midwest, USA
VERMES Microdispensing opens new office in Midwest, USA
Columbus, Ohio - June 14th, 2022 - VERMES Microdispensing, a world leader in the design and manufacture of innovative microdispensing solutions, is proud to announce its opening of another office location in the United States of America. The new office in Plain City, Ohio signifies VERMES Microdispensing's continued global growth and development. With this step, the German company aims to bring its superior microdispensing system solutions and support services closer to the

All 4 Releases


More Releases for MDS

Plan Your Career as a Dental Assistant: Enroll In MDS Dental Assistance Academy
FOR IMMEDIATE RELEASE Contact Street: 1415 El Camino Real City: San Mateo State: California Post Code: 94402 Country: USA Telephone: 1-888-637-4732 Email: info@mds4rda.com Website: https://dentalassistanceschool.com/ August 18th, 2022, California: Working as a dental assistant is a gateway to a rewarding career and a good thing is that you need not spend years when getting trained in professional schools. It does not take years to complete the training in a dental assistant school near me. All it requires
MDS Dental Assisting Academy Brings Flexible Dental Assisting Courses Online
CONTACT: MDS Dental Assisting Academy Address: 122 Thicket Lane City: Freedom State: California Postcode: 95019 Country: USA Telephone: 1-888-637-4732 Website: https://dentalassistanceschool.com/ Email: info@mds4rda.com California, January 28th, 2022: Are you interested in dentistry? What do you think of a career in dental assisting? If being a dental assistant is your career choice, then an RDA program in MDS Dental Assisting Academy will suit you the best. They provide an interactive course
CASwell Secures Products Against MDS Attacks
New firmware updates for network devices & servers against ZombieLoad, RIDL & Fallout Taipei, Taiwan - August 27th, 2019 - CASwell Inc., a leading manufacturer of innovative and high-performance server solutions for SD-WAN (uCPE/vCPE) and network security systems, announced today that most of its network devices and servers have received updates for their firmware or BIOS making them secure against any malicious attacks based on MDS vulnerabilities. With these updates customers
Myeloidysplastic Syndromes (MDS) – Epidemiology Insights (2016-2028)
Myeloidysplastic syndromes (MDS) can be described as a group of hematologic malignancies, that occurr due to abnormality in blood-forming cells in the bone marrow. It is a rare blood cancer and can be mild, moderate or severe, in terms of severity. Download the sample report @ https://www.pharmaproff.com/request-sample/1162 This syndrome can be classified into three main types: MDS with single lineage dysplasia wherein a single type of blood cell appears abnormal; multilineage
Myelodysplastic Syndrome (MDS) Treatment Market Industry Forecast till 2025
Myelodysplastic (MDS) syndrome is a type of bone marrow disorder, where bone marrow is unable to produce healthy and mature blood cells. The immature blood cells called as blasts, get stored in the bone marrow and blood and obstruct the natural function of the hematological system which results in depletion of healthy red blood cells, platelets, and white blood cells. Myelodysplastic syndrome is usually seen in geriatric population and more
Myelodysplastic Syndrome (MDS) Treatment Market - Global Industry Insights 2025
Myelodysplastic syndrome (MDS) is a disorder, which affects the bone marrow and produces immature blood cells. Bone marrow failure leads to lowering the levels of healthy blood cells circulation in the bloodstream. According to Seattle Cancer Care Alliance, around 80%-85% of people with MDS have more cells in their bone marrow than healthy people. According to National Organization for Rare Disorders, MDS deteriorates into a form of cancer in around